<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>overcoming chemotherapy resistance &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/overcoming-chemotherapy-resistance/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 09:52:34 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>overcoming chemotherapy resistance &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Nerolidol and Cyclophosphamide Combat Breast Cancer Cells</title>
		<link>https://bioengineer.org/nerolidol-and-cyclophosphamide-combat-breast-cancer-cells/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 19 Aug 2025 06:59:02 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Apoptosis in MCF-7 cells]]></category>
		<category><![CDATA[Breast cancer combination therapy]]></category>
		<category><![CDATA[Nerolidol-cyclophosphamide synergy]]></category>
		<category><![CDATA[overcoming chemotherapy resistance]]></category>
		<category><![CDATA[Plant-derived anticancer agents]]></category>
		<guid isPermaLink="false">https://bioengineer.org/nerolidol-and-cyclophosphamide-combat-breast-cancer-cells/</guid>

					<description><![CDATA[In the relentless quest to conquer cancer, researchers continuously strive to unlock new avenues for effective treatment strategies. A recent breakthrough study has shed light on the potent anticancer properties of nerolidol, a naturally occurring compound, both alone and in combination with cyclophosphamide, a well-established chemotherapeutic agent, against the widely studied MCF-7 breast cancer cell [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">256288</post-id>	</item>
		<item>
		<title>Breakthrough Method Connects Young Cancer Patients with Optimal Drug Treatments</title>
		<link>https://bioengineer.org/breakthrough-method-connects-young-cancer-patients-with-optimal-drug-treatments/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 01 Apr 2025 10:19:41 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[chicken egg tumor model]]></category>
		<category><![CDATA[genomic-proteomic integration]]></category>
		<category><![CDATA[overcoming chemotherapy resistance]]></category>
		<category><![CDATA[pediatric cancer proteomics]]></category>
		<category><![CDATA[personalized drug therapies]]></category>
		<guid isPermaLink="false">https://bioengineer.org/breakthrough-method-connects-young-cancer-patients-with-optimal-drug-treatments/</guid>

					<description><![CDATA[A groundbreaking innovation in the realm of pediatric oncology has emerged from a collaborative research effort led by the University of British Columbia and the BC Children’s Hospital Research Institute. This pan-Canadian team’s state-of-the-art technique enables the rapid identification of personalized treatment options for young cancer patients by leveraging an unexpected biological model: chicken eggs. [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">239670</post-id>	</item>
	</channel>
</rss>
